文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

偏头痛诊断标准我们遗漏了什么?

What Are We Missing in the Diagnostic Criteria for Migraine?

机构信息

George Washington University-Medical Faculty Associates, 2150 Pennsylvania Ave, NW, 7th Floor, Washington, DC, 20037, USA.

George Washington University-Medical Faculty Associates, Washington, DC, USA.

出版信息

Curr Pain Headache Rep. 2018 Oct 5;22(12):84. doi: 10.1007/s11916-018-0733-1.


DOI:10.1007/s11916-018-0733-1
PMID:30291572
Abstract

PURPOSE OF REVIEW: This review is intended to examine how the diagnostic criteria for migraine have evolved over the past 45 years and to evaluate the strengths and weaknesses of the current diagnostic criteria promulgated by the International Classification of Headache Disorders (ICHD). RECENT FINDINGS: The ICHD is a comprehensive and systematic classification system for headache disorders. As the pathophysiology of migraine is more fully elucidated and more sophisticated diagnostic technologies are developed (e.g., the identification of biomarkers), the current diagnostic criteria for migraine will likely be further refined. The ICHD has allowed for more precise research study design in the field of headache medicine. The current diagnostic criteria for migraine outlined in the 3rd version of the ICHD are far more sensitive and specific than the clinical criteria proposed in 1962. In future iterations, dividing episodic and chronic migraine into subtypes based on frequency (i.e., low frequency vs high frequency; near-daily vs daily) potentially could assist in guiding clinical management. In addition, a better understanding of aura, vestibular migraine, migrainous infarction, and hemiplegic migraine likely will lead to more refined diagnostic criteria for those entities.

摘要

目的综述: 本篇综述旨在探讨偏头痛的诊断标准在过去 45 年中的演变过程,并评估目前由国际头痛疾病分类(ICHD)发布的诊断标准的优缺点。

最近的发现: ICHD 是一种全面而系统的头痛疾病分类系统。随着偏头痛的病理生理学得到更充分的阐明,以及更复杂的诊断技术得到发展(例如,生物标志物的识别),目前的偏头痛诊断标准可能会进一步得到完善。ICHD 使得头痛医学领域的研究设计更加精确。与 1962 年提出的临床标准相比,ICHD 第 3 版中列出的偏头痛现行诊断标准的敏感性和特异性要高得多。在未来的迭代中,根据频率(即低频率与高频率;近每日与每日)将发作性和慢性偏头痛分为亚型,可能有助于指导临床管理。此外,对先兆、前庭性偏头痛、偏头痛性梗死和偏瘫性偏头痛的更好理解可能会导致这些病症的诊断标准更加完善。

相似文献

[1]
What Are We Missing in the Diagnostic Criteria for Migraine?

Curr Pain Headache Rep. 2018-10-5

[2]
Migralepsy: a call for a revision of the definition.

Epilepsia. 2009-11

[3]
Field-testing of the ICHD-3 beta/proposed ICD-11 diagnostic criteria for migraine with aura.

Cephalalgia. 2015-8

[4]
ICHD-3: what changes do we need regarding migraine?

Curr Pain Headache Rep. 2011-6

[5]
Polygenic risk provides biological validity for the ICHD-3 criteria among Finnish migraine families.

Cephalalgia. 2022-4

[6]
Headache classification: criticism and suggestions.

Neurol Sci. 2004-10

[7]
Chronic migraine classification: current knowledge and future perspectives.

J Headache Pain. 2011-10-26

[8]
Diagnostic criteria for CADASIL in the International Classification of Headache Disorders (ICHD-II): are they appropriate?

J Headache Pain. 2010-3-12

[9]
A redefinition of primary headache: chronic migraine.

Neurol Sci. 2012-5

[10]
Use of the ICHD-II criteria in the diagnosis of pediatric migraine.

Headache. 2005

引用本文的文献

[1]
Application of EEG in the Diagnosis and Classification of Migraine: A Scoping Review.

Cureus. 2024-7-19

[2]
Prevalence of migraine in Iran: a systematic review and meta-analysis.

BMC Neurol. 2023-4-27

[3]
Eptinezumab-jjmr, a humanized monoclonal specific to Calcitonin Gene Related Peptide, for the preventive treatment of migraine in adults.

Health Psychol Res. 2022-11-12

[4]
Migraine and Cochlear Symptoms.

Curr Med Sci. 2021-8

[5]
Daily Headache in Chronic Migraine Is a Predictive Factor of Response in Patients Who Had Completed Three Sessions of OnabotulinumtoxinA.

Toxins (Basel). 2021-6-21

[6]
Validation of an algorithm for automated classification of migraine and tension-type headache attacks in an electronic headache diary.

J Headache Pain. 2020-6-12

[7]
Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine - an updated systematic review and meta-analysis.

BMC Neurol. 2020-2-15

本文引用的文献

[1]
Lipidomic analysis of serum samples from migraine patients.

Lipids Health Dis. 2018-2-2

[2]
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition.

Cephalalgia. 2018-1

[3]
Neuronal Dysexcitability May Be a Biomarker of Migraine: A Visual Evoked Potential Study.

Clin EEG Neurosci. 2018-9

[4]
Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods.

Pain. 2007-4

[5]
No increase of calcitonin gene-related peptide in jugular blood during migraine.

Ann Neurol. 2005-10

[6]
Neurobiology in primary headaches.

Brain Res Brain Res Rev. 2005-6

[7]
Classification of headaches.

Cephalalgia. 2001-9

[8]
2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study.

Headache. 2000

[9]
Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks.

Pain. 2000-5

[10]
Responsiveness of non-IHS migraine and tension-type headache to sumatriptan.

Cephalalgia. 1997-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索